ISB News

ISB’s Cancer Genomics Cloud Team Launches BigQuery Platform

Genomeweb published an article on the Cancer Genomics Cloud pilots. Learn more about ISB’s CGC project.

PDF: Cancer Genomics Cloud Pilot Developers Provide Update, Open Up Platforms for Early Testing | GenomeWeb

NEW YORK (GenomeWeb) – The developers of the three proposals selected by the National Cancer Institute for the Cancer Genomics Cloud pilots — an effort to build sustainable computing infrastructure for analyzing omics data from the Cancer Genome Atlas and other NCI-funded projects — have begun various stages of testing ahead of the nine-month evaluation phase of the initiative, which is slated to begin in January 2016 when the first versions of all three platforms will be made available.

The proposals selected for the NCI initiative include one from Seven Bridges Genomics; one from the Institute for System Biology working in collaboration with Google and SRA International; and one from the Broad Institute in partnership with University of California, Berkeley and UC Santa Cruz.

Recent Articles

  • 2024 Year in Review

    Reflecting on the past year, ISB has a lot to celebrate: groundbreaking research published in leading scientific journals, well-earned promotions, widespread media coverage, and more. Enjoy our year-in-review roundup highlighting some of the important, interesting, and impactful highlights of 2024.

  • My Digital Gut

    ISB Named Winner of 2024-2025 Amazon Web Services IMAGINE Grant for Nonprofits

    ISB has been selected as a winner of the 2024 Amazon Web Services (AWS) IMAGINE Grant. The grant will support ISB’s continued development of My Digital Gut, an online decision-support platform that will help make microbiome-informed nutrition and healthcare personalized, predictive, and preventive. 

  • ISB-Developed MetaboCore Offers Precision Cancer Care Faster Than Ever 

    ISB Associate Professor Dr. Wei Wei and his colleagues have developed a promising new companion diagnostic tool called MetaboCore to help physicians quickly select the most effective systemic therapy for each cancer patient.